Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Free Articles

These articles are provided free to all readers.  Other free articles are available in Week in Review, In My Opinion, and Education Center.  To have access to all of our articles, click here...

Week in Review: Adlai Nortye Stages $97.5 Million US IPO on NASDAQ

Week in Review: Everest Acquires Novel Autoimmune Therapy in $132 Million Agreement

Week in Review: Hasten Signs $325 Million Deal for China Rights to PCSK9 Cholesterol Therapy

Week in Review: Grit Bio Raises $60 Million for Tumor-Infiltrating Lymphocyte Drugs

Week in Review: GenFleet Out-Licenses Three Candidates to Verastem in $625 Million Deal

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China